Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit
Provided By PR Newswire
Last update: May 18, 2023
NEW YORK, May 18, 2023 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that Chief Scientific Officer Dr. Miriam Kidron will deliver an in-person presentation at the Novel Therapies for Type 2 Diabetes & Obesity Summit in Boston, MA, on May 31, 2023. The presentation will include an overview of Oramed's oral delivery technology as well as insights from the Company's recent Phase 3 oral insulin clinical trials.
Read more at prnewswire.com2
-0.09 (-4.31%)
Find more stocks in the Stock Screener
ORMP Latest News and Analysis
19 days ago - ChartmillUnusual volume stocks in Wednesday's sessionDiscover the stocks with unexpected trading volume in today's session on the US markets.
20 days ago - ChartmillWhat's going on in today's sessionKeep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
